Holen Sie sich die Stockscreener-App
328.18
0.16%
0.51
Schlusskurs vom Vortag:
$327.67
Offen:
$323.92
24-Stunden-Volumen:
968.03K
Relative Volume:
0.71
Marktkapitalisierung:
$47.31B
Einnahmen:
$2.50B
Nettoeinkommen (Verlust:
$-226.32M
KGV:
-199.96
EPS:
-1.6412
Netto-Cashflow:
$71.51M
1W Leistung:
+0.59%
1M Leistung:
+19.26%
6M Leistung:
+61.64%
1J Leistung:
+97.03%
1-Tages-Spanne:
$323.42
$329.05
1-Wochen-Bereich:
$316.00
$332.00
52-Wochen-Spanne:
$157.43
$343.18
Natera Inc Stock (NTRA) Company Profile
Firmenname
Natera Inc
Sektor
Branche
Telefon
650-249-9090
Adresse
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IQV, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
328.18 | 46.82B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
613.78 | 232.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
207.66 | 151.78B | 24.78B | 3.68B | 5.29B | 5.1743 |
IQV
Iqvia Holdings Inc
|
267.77 | 42.15B | 16.63B | 1.39B | 2.12B | 8.0674 |
A
Agilent Technologies Inc
|
150.86 | 44.14B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Eingeleitet | William Blair | Outperform |
| 2026-01-07 | Eingeleitet | Citigroup | Buy |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-10-27 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-03-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-08 | Fortgesetzt | Craig Hallum | Buy |
| 2024-02-20 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-11-13 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-01-18 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2022-03-08 | Eingeleitet | Goldman | Buy |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-09-28 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-09-17 | Eingeleitet | SVB Leerink | Outperform |
| 2020-06-10 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-05-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-10-05 | Eingeleitet | JP Morgan | Neutral |
| 2018-07-05 | Bestätigt | Piper Jaffray | Overweight |
| 2017-08-07 | Bestätigt | Morgan Stanley | Overweight |
| 2016-11-10 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-05-11 | Bestätigt | The Benchmark Company | Buy |
| 2016-04-19 | Eingeleitet | The Benchmark Company | Buy |
| 2015-09-28 | Hochstufung | Wedbush | Neutral → Outperform |
| 2015-08-14 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2015-07-27 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2015-07-27 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-07-27 | Eingeleitet | Wedbush | Neutral |
Alle ansehen
Natera Inc Aktie (NTRA) Neueste Nachrichten
Net income before discontinued operations of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRAD - TradingView
Diluted earnings per share (diluted EPS) of NATERA INC CEDEAR EACH 51 REPR 1 COM (USD) – BCBA:NTRA.CI - TradingView
Gross profit of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA - TradingView
NATERA INC CEDEAR EACH 51 REPR 1 COM (USD) Revenue Breakdown – BCBA:NTRA.CI - TradingView
Natera Inc Cert Deposito Arg Repr 0.019607 Sh Revenue Breakdown – BCBA:NTRA - TradingView
Guggenheim maintains Buy on Natera, raises target to $290 - scanx.trade
Net income before discontinued operations of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRAC - TradingView
The Bull Case For Natera (NTRA) Could Change Following New Signatera Lymphoma Data And Komen Partnership - simplywall.st
Natera CEO Steven Chapman sells $545k in NTRA shares By Investing.com - Investing.com South Africa
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years - benzinga.com
Natera stock trades near 52-week high as guidance and regulatory wins support growth - AD HOC NEWS
Natera Inc (NTRA) CEO and President Steven Chapman Sells 1,698 S - GuruFocus
Natera president Solomon Moshkevich sells over $5.9m in shares - Investing.com
Natera president Solomon Moshkevich sells over $5.9m in shares By Investing.com - Investing.com Nigeria
Natera CEO Steven Chapman sells $545k in NTRA shares - Investing.com
Natera (NASDAQ: NTRA) exec sells shares for taxes and under pre-set plan - stocktitan.net
Natera Unlocks Broader Signatera Adoption With FDA, PMDA And NCCN Milestones! - Smartkarma
Natera: $8.25M Prenatal Test Class Action Settlement Approved - Wansom AI
After recent stock sales, Natera (NASDAQ: NTRA) exec files notice to sell more shares - stocktitan.net
Planned stock sale by Natera (NTRA) holder follows 41,124-share trade - stocktitan.net
Natera (NASDAQ: NTRA) executive plans nearly $1M share sale after $2M in recent trades - stocktitan.net
NTRA Looks 47.2% Overvalued on GF Value™ - GuruFocus
New Publication Establishes Strong Clinical Validation of Signatera™ for MRD Assessment in Lymphoma - stocktitan.net
Pretax income of Natera, Inc. – LSX:A14VPJ - TradingView
Natera, Inc. (NTRA) Stock Analysis: A Healthcare Powerhouse with a 3.21% Upside Potential - DirectorsTalk Interviews
Natera Stock (NTRA) Opinions on Recent Price Surge - moomoo.com
Natera president John Fesko sells $2.1m in company stock By Investing.com - Investing.com Nigeria
Natera & Angiex Partner to Evaluate AGX101 Response With Signatera - easternprogress.com
Natera president John Fesko sells $2.1m in company stock - Investing.com
Natera partners with Angiex for cancer drug trial testing - Investing.com
Is Natera’s (NTRA) Kupando MRD Deal a Stepping Stone in Its Oncology Strategy? - simplywall.st
Natera: The Growth May Not Justify Current Levels - Seeking Alpha
Natera’s Oncology Push Has Wall Street Paying Up - Finimize
Natera Inc. Earnings Call Highlights Rapid Growth - TipRanks
Natera raises FY26 guidance to $2.85B-$2.91B after record Q2 volume - scanx.trade
Silvant Capital Management LLC Takes $12.32 Million Position in Natera, Inc. $NTRA - MarketBeat
Virtus Advisers LLC Takes $1.01 Million Position in Natera, Inc. $NTRA - MarketBeat
Ninepoint Partners LP Purchases New Position in Natera, Inc. $NTRA - MarketBeat
D L Carlson Investment Group Inc. Makes New $3.49 Million Investment in Natera, Inc. $NTRA - MarketBeat
Deutsche Bank AG Purchases Shares of 320,037 Natera, Inc. $NTRA - MarketBeat
Danske Bank A S Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Natera, Inc. (NASDAQ:NTRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Natera (NTRA) Earnings Snapshot: Profit Per Share Surpasses Its Benchmark; Price Reaction: The Stock Loses 0.07% at the CloseEPS Guidance Update - vinanet.vn
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? - AOL.com
Natera stock reaches all-time high at 326.26 USD By Investing.com - Investing.com Australia
Natera (NASDAQ:NTRA) Reaches New 1-Year HighTime to Buy? - MarketBeat
Natera stock reaches all-time high at 326.26 USD - Investing.com
Natera (NTRA) Q2 2026 Results: The Bottom-Line Figure Outpaces Its Comparison at the Close; Latest Reaction - vinanet.vn
Mitsubishi UFJ Asset Management Co. Ltd. Takes $50.42 Million Position in Natera, Inc. $NTRA - MarketBeat
Edmond DE Rothschild Holding S.A. Takes Position in Natera, Inc. $NTRA - MarketBeat
Eagle Health Investments LP Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Finanzdaten der Natera Inc-Aktie (NTRA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Natera Inc-Aktie (NTRA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Sep 01 '26 |
Sale |
320.73 |
3,000 |
962,194 |
126,019 |
| Chapman Steven Leonard | CEO AND PRESIDENT |
Sep 01 '26 |
Sale |
320.99 |
1,698 |
545,041 |
98,199 |
1.42%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):